Researchers at Ohio University have discovered what may be a new way to fight lung cancer that is resistant to other treatments. The study published in the International Journal of Molecular Science ...
Researchers at Ohio University have discovered what may be a new way to fight lung cancer that is resistant to other treatments. The study, published in the International Journal of Molecular Science ...
Researchers at Ohio University have discovered what may be a new way to fight lung cancer that is resistant to other treatments.
Radiation therapy is a cornerstone of lung cancer treatment. But even when delivered with precision, radiation can damage healthy lung tissue. "Try as we might, when we deliver radiation to a cancer, ...
The trust that runs the major hospitals in Shropshire is taking part in a new lung cancer study to find alternative ...
As a nonsmoker lung cancer hasn't been a concern of mine, but I recently heard it can affect people who have never smoked. If ...
Daiichi Sankyo announced that the first patient has been dosed in the global phase 3 TROPION-Lung17 trial. The study is evaluating DATROWAY in patients with locally advanced or metastatic nonsquamous ...
Researchers at Wake Forest University School of Medicine developed engineered immune cells that can cross the blood-brain barrier and slow lung cancer brain metastases, offering a promising new ...
Malaysia has a new national plan to tackle cancer, tuberculosis, and chronic respiratory conditions in a single approach. Jacqui Thornton reports.
Suchan still needed chemotherapy and radiation, but Salgia credits Rybrevant for shrinking her tumors 60 to 70%. It specifically targets her cancer cells and revs up the immune system. For a year and ...
The U.S. Food and Drug Administration said on Thursday it approved Boehringer Ingelheim's drug for patients with a type of advanced lung cancer who have received prior treatment, marking the second ...
Boehringer Ingelheim received approval from the Food and Drug Administration for Hernexeos as a treatment for lung cancer. The newly approved indication was granted under accelerated approval based on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results